CEO Americas
Mr Richardson has more than 25 years’ experience in the healthcare industry including seven years focused in sales, marketing and business operations in the radiopharmaceutical segment. Immediately prior to Telix, Kevin was the Chief Operating Officer of UroShape Medical, a technology company which has developed and successfully commercialized a medical device for a large, undertreated segment in the women’s health market. Prior to this, he spent seven years in the Americas division of Sirtex Medical, an Australian-founded radiopharmaceutical company which commercialized a device for the treatment of liver cancer. During his tenure, firstly as Head of Sales, and then subsequently in the roles of General Manager and CEO Americas, Kevin oversaw a five-fold increase in sales for the U.S. region. Kevin has also held senior sales roles with St Jude Medical and Boston Scientific. He holds an MBA from the University of Texas.